We are live on ! Find out more
BSPM

Biostar Pharmaceuticals, Inc.
BSPM

Delisted

BSPM was delisted on the 18th of September, 2018.

Back to rankings

1 hedge funds and large institutions have $1K invested in Biostar Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $1K → $1K ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$1K – – –

BSPM Hedge Fund Activity: Q2 2019 in Review

1 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q2 2019, worth a combined $1K — unchanged from a quarter earlier.

Fund positioning in BSPM was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Biostar Pharmaceuticals, Inc. (BSPM) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $1K of Biostar Pharmaceuticals, Inc. stock for Q2 2019, unchanged quarter-over-quarter.
  • 0 funds opened new Biostar Pharmaceuticals, Inc. positions in Q2 2019 and 0 closed out.

Based on aggregated 13F filings for Q2 2019.